R&D How predictive safety can help patients Adverse events due to drug consumption can damage the physical and mental wellbeing of patients and are a huge economic burden for the healthcare system (Sultana et al., 2013).
News Corcept gets FDA OK for first-in-class ovarian cancer drug Corcept shares surge on FDA approval of Lifyorli, a first-in-class selective glucocorticoid receptor antagonist for ovarian cancer.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.